(S (S (VP (VBG Identifying) (NP (NP (JJ patient) (NNS characteristics)) (SBAR (WHNP (WDT that)) (S (VP (VBP influence) (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (JJ colorectal) (NN polyp) (NN recurrence)))))))))) (VP (MD can) (VP (VB provide) (NP (JJ important) (NNS insights)) (PP (IN into) (SBAR (WHNP (WDT which)) (S (NP (NNS patients)) (VP (VBP are) (PP (IN at) (NP (NP (JJR higher) (NN risk)) (PP (IN for) (NP (NN recurrence))))))))))) (. .))
(S (NP (PRP We)) (VP (VBD used) (NP (NML (JJ natural) (NN language)) (NN processing)) (S (VP (TO to) (VP (VB extract) (NP (NN polyp) (JJ morphological) (NNS characteristics)) (PP (IN from) (NP (NP (CD 953) (NML (NN polyp) (HYPH -))) (VP (VBG presenting) (NP (NP (NNS patients) (POS ')) (JJ electronic) (JJ medical) (NNS records))))))))) (. .))
(S (NP (PRP We)) (VP (VBD used) (SBAR (S (NP (JJ subsequent) (NN colonoscopy)) (VP (VBZ reports) (S (VP (TO to) (VP (VB examine) (SBAR (WHADVP (WRB how)) (S (NP (DT the) (NN time) (S (VP (TO to) (VP (VB polyp) (NP (NN recurrence)) (PRN (-LRB- -LRB-) (S (NP (CD 731) (NNS patients)) (VP (VBD experienced) (NP (NN recurrence)))) (-RRB- -RRB-)))))) (VP (VBZ is) (VP (VBN influenced) (PP (IN by) (NP (NP (DT these) (NNS characteristics)) (CONJP (RB as) (RB well) (IN as)) (NP (JJ anthropometric) (NNS features)))) (S (VP (VBG using) (NP (NP (NP (NNP Kaplan) (HYPH -) (NNP Meier)) (NP (NNS curves))) (, ,) (NP (NP (NNP Cox) (JJ proportional) (NNS hazards)) (NP (NN modeling))) (, ,) (CC and) (NP (NML (JJ random) (NN survival) (NN forest)) (NNS models)))))))))))))))) (. .))
(S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (NN recurrence)))) (VP (VBD differed) (ADVP (RB significantly)) (PP (IN by) (NP (NP (NN polyp) (NN size)) (, ,) (NP (NN number)) (, ,) (CC and) (NP (NML (NN location) (CC and) (NN patient)) (NN smoking) (NN status)))))))) (. .))
(S (ADVP (RB Additionally)) (, ,) (NP (ADJP (JJ right) (HYPH -) (JJ sided)) (NN colon) (NNS polyps)) (VP (VBD increased) (NP (NN recurrence) (NN risk)) (PP (IN by) (NP (CD 30) (NN %))) (PP (VBN compared) (PP (IN to) (NP (ADJP (JJ left) (HYPH -) (JJ sided)) (NNS polyps))))) (. .))
(S (NP (NP (NN History)) (PP (IN of) (NP (NN tobacco) (NN use)))) (VP (VBD increased) (NP (NN polyp) (NN recurrence) (NN risk)) (PP (IN by) (NP (NP (CD 20) (NN %)) (PP (VBN compared) (PP (IN to) (ADVP (RB never)))) (PP (HYPH -) (NP (NNS users)))))) (. .))
(S (NP (DT A) (NML (JJ random) (NN survival) (NN forest)) (NN model)) (VP (VP (VBD showed) (NP (NP (DT an) (NN AUC)) (PP (IN of) (NP (CD 0.65))))) (CC and) (VP (VBD identified) (NP (NP (JJ several) (JJ other) (JJ predictive) (NNS variables)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD can) (VP (VB inform) (NP (NP (NN development)) (PP (IN of) (NP (VBN personalized) (NN polyp) (NN surveillance) (NNS plans))))))))))) (. .))
